Pricing
  1. US-listed companies
  2. Avid Bioservices, Inc.
  3. Financials
  4. Cash from financing

Avid Bioservices, Inc. (CDMO)

Market cap
$798.9M
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Apr 30, 202420+591.73%
Apr 30, 20233-9.26%
Apr 30, 20223-97.15%
Apr 30, 2021112+10149.54%
Apr 30, 20201-138.28%
Apr 30, 2019-3-112.87%
Apr 30, 201822-21.00%
Apr 30, 201728-32.61%
Apr 30, 201642+19.48%
Apr 30, 201535-52.12%
Apr 30, 201473+88.07%
Apr 30, 201339+21.37%
Apr 30, 201232

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat